This is in line with current literature: reduced MHC-I expression is well-known to facilitate immune evasion (Šmahel, 2017); MHC-II expression is correlated with response to PD-1 blockade treatment (Rodig et al., 2018); and HSP genes are associated with tumor proliferation and metastasis (Ciocca and Calderwood, 2005). This evidence concerns the gene HSP90B2P and neoplasm.